Related Articles
Exciting progress in the fight against obesity
Read More
RenBio is excited to provide an update on our ultra long-acting GLP-1 receptor agonist program.
Read More
RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO TechnologyTM Platform for Antiviral Applications
Read More
More News & Events